Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cancer Management and Research|December 13, 2018
Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1<sup>*</sup>6 or UGT1A1<sup>*</sup>28Chuan Tian, Haifeng Ying, Rongyuan Zhuang, et al.
ACS Nano|January 15, 2016
Graphene Oxides Decorated with Carnosine as an Adjuvant To Modulate Innate Immune and Improve Adaptive Immunity in VivoChunchun Meng, Xiao Zhi, Chao Li, et al.
Cancer Biology & Therapy|March 10, 2017
Correlative analysis of plasma SN-38 levels and DPD activity with outcomes of FOLFIRI regimen for metastatic colorectal cancer with UGT1A1 *28 and *6 wild type and its implication for individualized chemotherapyXun Cai, Chuan Tian, Liwei Wang, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
American Journal of Cancer Research|October 17, 2024
Utidelone-based therapy in advanced or metastatic solid tumors after failure of standard therapies: a prospective, multicenter, single-arm trialGuanglei Qiao, Zimei Liu, Honghua Ding, et al.
Thoracic Cancer|December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in ChinaYuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Pageof 5